Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cytokinetics Inc (CYTK)  
$53.78 2.03 (3.92%) as of 4:30 Thu 6/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 122,563,000
Market Cap: 6.59(B)
Last Volume: 8,264,325 Avg Vol: 8,242,049
52 Week Range: $26.88 - $108.06
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 138,093 288,980 461,958 926,280
Total Sell Value $8,135,395 $19,867,810 $25,677,895 $46,442,456
Total People Sold 7 8 8 12
Total Sell Transactions 11 21 41 87
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 1115
  Page 44 of 45  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Trautman Jay K VP, Disc Biology & Technology   •       –      –    2005-11-03 4 S $7.55 $139,099 D/D (18,100) 30,160     -
   Trautman Jay K VP, Disc Biology & Technology   •       –      –    2005-11-03 4 S $7.03 $101,877 D/D (13,900) 48,260     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2005-11-03 4 S $7.62 $176,000 D/D (22,500) 0     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2005-11-02 4 S $7.34 $93,192 D/D (12,500) 22,500     -
   Sabry James H President and CEO   •       •      –    2005-07-21 4 GD $0.00 $0 D/D 1,000 0     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-07-13 4 GD $0.00 $0 D/D 5,000 65,000     -
   Sabry James H President and CEO   •       •      –    2005-05-13 4 GD $0.00 $0 D/D 31,000 219,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-02-25 4 S $9.66 $48,323 D/D (5,000) 68,750     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-02-24 4 S $9.25 $46,250 D/D (5,000) 73,750     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2005-02-14 4 S $9.50 $95,000 D/D (10,000) 78,750     -
   Heidrich A Grant III See Explanation of Responses   –       •      –    2004-11-29 4 S $8.80 $135,540 I/I (15,400) 93,755     -
   Heidrich A Grant III See Explanation of Responses   –       •      –    2004-11-26 4 S $8.72 $87,235 I/I (10,000) 94,525     -
   Heidrich A Grant III See Explanation of Responses   –       •      –    2004-11-24 4 S $8.56 $638,397 I/I (74,600) 95,025     -
   Dow Stephen M Director   –       •       •   2004-10-28 4 B $8.91 $179,954 I/I 20,000 60,000 2.25     -
   Dow Stephen M Director   –       •       •   2004-10-27 4 B $8.17 $329,611 I/I 40,000 40,000 2.25     -
   Hemisphere Private Equity Partners Charitable Trus 10% Owner   –       –       •   2004-05-04 4 A $0.00 $0 I/I 1,765,683 1,765,683     -
   Hemisphere Private Equity Partners Charitable Trus 10% Owner   –       –       •   2004-05-04 4 A $0.00 $0 I/I 1,339,580 1,339,580     -
   Dalal Yogen K See Explanation of Responses   –       –      –    2004-05-04 4 A $0.00 $0 I/I 255,355 13,705     -
   Dalal Yogen K See Explanation of Responses   –       –      –    2004-05-04 4 A $0.00 $0 D/D 1,876,358 1,876,358     -
   Dow Stephen M Director   –       •      –    2004-04-29 4 A $0.00 $0 I/I 3,164,002 3,164,002     -
   Rutter William J Director   –       •      –    2004-04-29 4 OE $12.00 $2,068,956 D/D 172,413 172,413     -
   Schmertzler Michael Director   –       •       •   2004-04-29 4 OE $12.00 $37,263,132 I/I 3,105,261 3,105,261     -
   Srb Associates VIII Lp 10% Owner   –       –       •   2004-04-29 4 A $0.00 $0 I/I 771,052 771,052     -
   Sevin Rosen Vii Affiliates Fund Lp 10% Owner   –       –       •   2004-04-29 4 A $0.00 $0 D/D 24,050 24,050     -
   Sevin Rosen Fund Vii Lp 10% Owner   –       –       •   2004-04-29 4 A $0.00 $0 D/D 625,950 625,950     -
  1115 Records found
  Previous  40  41  42  43  44  45   
  Page 44 of 45
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us